Pfizer | PFE

Peers Price Chg Day Year Date
AbbVie 156.99 -1.51 -0.95% 13.25% May/24
Abbott 103.95 -0.34 -0.33% 1.77% May/24
ALKERMES 24.02 0.02 0.08% -18.24% May/24
Amgen 305.88 -0.63 -0.20% 40.66% May/24
AstraZeneca 12,296.00 -108.00 -0.87% 5.62% May/24
Bayer 28.27 0.64 2.32% -47.99% May/27
Biogen 217.88 -0.26 -0.12% -26.67% May/24
Bristol-Myers Squibb 41.22 -0.27 -0.65% -36.15% May/24
Catalent 54.76 0.08 0.15% 48.48% May/24
Gilead Sciences 65.67 -0.54 -0.82% -15.43% May/24
GlaxoSmithKline 1,774.50 -3.50 -0.20% 28.16% May/24
Glaxosmithkline 45.12 -0.03 -0.07% 32.28% May/24
J&J 147.04 -2.64 -1.76% -4.77% May/24
Eli Lilly 807.43 -0.91 -0.11% 88.96% May/24
Medtronic 82.28 0.98 1.21% -1.51% May/24
Merck 129.32 -1.55 -1.18% 15.16% May/24
Neurocrine Biosciences 139.40 -1.11 -0.79% 51.23% May/24
Novartis 92.03 0.29 0.32% 5.76% May/27
Novartis 100.54 -0.50 -0.49% 2.82% May/24
Prestige Brands 63.97 0.14 0.22% 9.63% May/24
Pacira 29.69 -0.63 -2.08% -25.29% May/24
Pfizer 28.87 0.16 0.56% -23.68% May/24
Perrigo 27.91 -0.20 -0.71% -14.14% May/24
Drreddys Laboratories 69.53 -0.08 -0.11% 27.67% May/24
Regeneron Pharmaceuticals 985.02 3.88 0.40% 35.86% May/24
Roche Holding 229.90 -0.50 -0.22% -20.15% May/27
Sanofi 89.86 0.34 0.38% -9.19% May/27
Sanofi 48.54 -0.46 -0.94% -7.70% May/24
Vertex Pharmaceuticals 455.08 6.03 1.34% 36.81% May/24
Zoetis 170.13 -0.87 -0.51% 2.96% May/24

Indexes Price Day Year Date
US500 5307 -0.58 -0.01% 26.19% May/28

Pfizer traded at $28.88 this Friday May 24th, increasing $0.16 or 0.56 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 14.20 percent. Over the last 12 months, its price fell by 23.66 percent. Looking ahead, we forecast Pfizer to be priced at 28.56 by the end of this quarter and at 27.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.